Bristol Myers Squibb Presents New Data at Digestive Disease Week® on Zeposia (ozanimod) Highlighting Clinical Benefits and Safety Profile in Patients with Ulcerative Colitis

On May 23, 2021

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219

Related Post

Modification to the Methodology of the S&P ESG Leaders Indices

Modification to the Methodology of the S&P Carbon Control Index Series

MACOM Technology Solutions Holdings Set to Join S&P MidCap 400